Enhancing CAR T Cell Therapy Through In Silico Modeling of Hinge Sequence Length Based on Epitope Location

Investigators built an in silico model combining Alphafold2 (AF2) and all-atom molecular dynamics to understand and predict an optimal hinge amino acid sequence length for a given single-chain variable fragment (scFv) targeting a specific cancer antigen.